The dapagliflozin in patients with myocardial infarction (DAPA-MI) trial in perspective

Eur Heart J Acute Cardiovasc Care. 2023 Dec 21;12(12):862-863. doi: 10.1093/ehjacc/zuad142.
No abstract available

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Diabetes Mellitus, Type 2*
  • Glucosides / therapeutic use
  • Heart Failure*
  • Humans
  • Myocardial Infarction* / complications
  • Myocardial Infarction* / drug therapy
  • Randomized Controlled Trials as Topic

Substances

  • Benzhydryl Compounds
  • dapagliflozin
  • Glucosides